The PFAS-lipid-frailty nexus: an interconnected pathway to healthy aging

References

[1] Fried, L. P.; Tangen, C. M.; Walston, J.; et al.; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype.J Gerontol A Biol Sci Med Sci2001;56:M146-56

[2] Chen X,Yao Y.The path to healthy ageing in China: a Peking University-Lancet Commission.Lancet2022;400:1967-2006 PMCID:PMC9801271

[3] Soysal P,Lucato P.Inflammation and frailty in the elderly: a systematic review and meta-analysis.Ageing Res Rev2016;31:1-8

[4] Angulo J,Rodríguez-Mañas L.Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults.Mol Aspects Med2016;50:1-32

[5] Xu Y,Chen D,Xiong Z.Inflammatory biomarkers in older adults with frailty: a systematic review and meta-analysis of cross-sectional studies.Aging Clin Exp Res2022;34:971-87

[6] Turkel I,Yılmaz M,Kubat GB.Mitochondrial transplantation as a possible therapeutic option for sarcopenia.J Mol Med2023;101:645-69

[7] Dupont J,Dalle S,Gielen E.The role of omega-3 in the prevention and treatment of sarcopenia.Aging Clin Exp Res2019;31:825-36 PMCID:PMC6583677

[8] Calder PC.Omega-3 fatty acids and inflammatory processes: from molecules to man.Biochem Soc Trans2017;45:1105-15

[9] Sunderland EM,Dassuncao C,Wagner CC.A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects.J Expo Sci Environ Epidemiol2019;29:131-47 PMCID:PMC6380916

[10] Evich MG,McCord JP.Per- and polyfluoroalkyl substances in the environment.Science2022;375:eabg9065 PMCID:PMC8902460

[11] Stanifer JW,Souma T,Zhao X.Perfluorinated chemicals as emerging environmental threats to kidney health: a scoping review.Clin J Am Soc Nephrol2018;13:1479-92 PMCID:PMC6218824

[12] Rosen EM,Knappe DRU.Drinking water-associated PFAS and fluoroethers and lipid outcomes in the GenX exposure study.Environ Health Perspect2022;130:97002 PMCID:PMC9450637

[13] Tancreda G,Sarti M,Vornoli A.Perfluoroalkyl substances (PFAS) and lipid metabolism in experimental animal models: a scoping review on the mechanisms behind the induced hepatotoxicity.Curr Issues Mol Biol2025;47:944 PMCID:PMC12650804

[14] Wielsøe M,Ghisari M.Perfluoroalkylated substances (PFAS) affect oxidative stress biomarkers in vitro.Chemosphere2015;129:239-45

[15] Liu B,Wang M.Associations between per- and polyfluoroalkyl substances exposures and blood lipid levels among adults - a meta-analysis.Environ Health Perspect2023;131:56001 PMCID:PMC10159273

[16] Salihovic S,Ganna A.Identification of metabolic profiles associated with human exposure to perfluoroalkyl substances.J Expo Sci Environ Epidemiol2019;29:196-205

[17] Ma X,Chen Q.Hunting metabolic biomarkers for exposure to per- and polyfluoroalkyl substances: a review.Metabolites2024;14:392 PMCID:PMC11278593

[18] Yang W,He S.PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: an integrated approach.Environ Int2023;178:108138

[19] Vanden Heuvel, J. P.; Thompson, J. T.; Frame, S. R.; Gillies, P. J. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha.Toxicol Sci2006;92:476-89

[20] Wolf CJ,Schmid JE,Abbott BD.Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths.Toxicol Sci2008;106:162-71

[21] Schlezinger JJ,Oliver J,Heiger-Bernays W.Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.Toxicol Appl Pharmacol2020;405:115204 PMCID:PMC7503133

[22] Heindel JJ,Cave M.Metabolism disrupting chemicals and metabolic disorders.Reprod Toxicol2017;68:3-33 PMCID:PMC5365353

[23] Le Magueresse-Battistoni, B.; Vidal, H.; Naville, D. Environmental pollutants and metabolic disorders: the multi-exposure scenario of life.Front Endocrinol2018;9:582 PMCID:PMC6176085

[24] Baumert BO,Walker DI.Translational framework linking perfluoroheptanoic acid (PFHpA) exposure to metabolic dysfunction associated steatotic liver disease in adolescents.Commun Med2025;5:430 PMCID:PMC12572386

[25] Gomis MI,Borg D.Comparing the toxic potency in vivo of long-chain perfluoroalkyl acids and fluorinated alternatives.Environ Int2018;113:1-9

[26] Wu B,Huang H.Efficient biodegradation and detoxification of 6:2 fluorotelomer sulfonic acid by Phanerochaete chrysosporium: insights into enzymatic mechanisms and reduced ecotoxicity.Chem Eng J2026;529:172664

[27] Calder PC.Very long-chain n-3 fatty acids and human health: fact, fiction and the future.Proc Nutr Soc2018;77:52-72

[28] Ferri E,Calvani R,Cesari M.Role of age-related mitochondrial dysfunction in sarcopenia.Int J Mol Sci2020;21:5236 PMCID:PMC7432902

[29] Kam Y,Romero N.Chain length-dependent mitochondrial toxicity of perfluoroalkyl carboxylic acids: insights from Mito Tox Index evaluation.Front Toxicol2025;7:1582891 PMCID:PMC12303941

[30] Jia X,Ling X.Sex and obesity influence the relationship between perfluoroalkyl substances and lean body mass: NHANES 2011-2018.Heliyon2024;10:e35888 PMCID:PMC11419868

[31] Huang Y,Cui H,Qi X.Mitochondrial dysfunction in age-related sarcopenia: mechanistic insights, diagnostic advances, and therapeutic prospects.Front Cell Dev Biol2025;13:1590524 PMCID:PMC12531180

[32] Serhan CN.Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators.J Clin Invest2018;128:2657-69 PMCID:PMC6025982

[33] Chiang N.Specialized pro-resolving mediator network: an update on production and actions.Essays Biochem2020;64:443-62 PMCID:PMC7682745

[34] Bischoff-Ferrari HA,Wieczorek M.Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial.Nat Aging2025;5:376-85 PMCID:PMC11922767

[35] McGlory C,Nunes EA.The influence of omega-3 fatty acids on skeletal muscle protein turnover in health, disuse, and disease.Front Nutr2019;6:144 PMCID:PMC6742725

[36] Kim J,Won CW.Erythrocyte levels of n-3 polyunsaturated fatty acids and incidence of frailty after a 6-year follow-up: the Korean frailty and aging cohort study.Front Nutr2025;12:1569832 PMCID:PMC12307219

[37] Gagesch M,Vellas B.Effects of vitamin D, omega-3 fatty acids and a home exercise program on prevention of pre-frailty in older adults: the DO-HEALTH randomized clinical trial.J Frailty Aging2023;12:71-7

[38] Hashidate-Yoshida T,Hishikawa D.Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport.Elife2015;4:e06328 PMCID:PMC4436788

[39] Domingo JL.Health risks of dietary exposure to perfluorinated compounds.Environ Int2012;40:187-95

[40] O’Donnell VB.New appreciation for an old pathway: the lands cycle moves into new arenas in health and disease.Biochem Soc Trans2022;50:1-11 PMCID:PMC9022965

[41] Meng L,Wang D.Specific lysophosphatidylcholine and acylcarnitine related to sarcopenia and its components in older men.BMC Geriatr2022;22:249 PMCID:PMC8957177

[42] Meng L,Wang DG.Specific metabolites involved in antioxidation and mitochondrial function are correlated with frailty in elderly men.Front Med2022;9:816045 PMCID:PMC8833032

[43] Takagi S,Takemura M.Low plasma lysophosphatidylcholine levels are associated with reduced handgrip strength in older outpatients.Geriatr Gerontol Int2026;26:e70281

[44] Sevastou I,Mouratis MA.Lysoglycerophospholipids in chronic inflammatory disorders: the PLA₂/LPC and ATX/LPA axes.Biochim Biophys Acta2013;1831:42-60

[45] Zou Y,Jung KJ.Lysophosphatidylcholine enhances oxidative stress via the 5-lipoxygenase pathway in rat aorta during aging.Rejuvenation Res2009;12:15-24

[46] Hung SC,Chan HC.Lysophosphatidylcholine impairs the mitochondria homeostasis leading to trophoblast dysfunction in gestational diabetes mellitus.Antioxidants2024;13:1007 PMCID:PMC11351454